Glycine conjugation: Importance in metabolism, the role of glycine N-acyltransferase, and factors that influence interindividual variation

Expert Opinion on Drug Metabolism and Toxicology

Volumn 9, Issue 9, 2013, Pages 1139-1153

  Badenhorst, Christoffel Petrus Stephanus ^a   Van Der Sluis, Rencia ^a   Erasmus, Elardus ^a   Van Dijk, Alberdina Aike ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Acyl coenzyme A; Benzoate; CASTOR disorder; Coenzyme A; Coenzyme A sequestration; GLYAT; Glycine conjugation; Glycine N acyltransferase; Hepatocellular carcinoma; Xenobiotics

Indexed keywords

ACYL COENZYME A; BENZOIC ACID; GLYCINE; LONG CHAIN FATTY ACID COENZYME A LIGASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

DRUG CONJUGATION; ENZYME METABOLISM; ENZYME SYNTHESIS; GENETIC VARIABILITY; GLUCURONIDATION; HEPATITIS; HUMAN; LIVER CANCER; MUSCULOSKELETAL DEVELOPMENT; PROTEIN DEPLETION; REVIEW; SIGNAL TRANSDUCTION;

ACYLTRANSFERASES; COENZYME A; GLYCINE; HEPATITIS; HUMANS; HYDROXYBENZOATES; KIDNEY; LIVER; LIVER NEOPLASMS; METABOLIC DETOXICATION, DRUG; MITOCHONDRIA; MUSCULOSKELETAL DEVELOPMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; XENOBIOTICS;

EID: 84882386100     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2013.796929     Document Type: Review

References (101)

1. Ure A. On gouty concretions; with a new method of treatment. Pharm J Trans 1841;1:24
2. Keller W. On the conversion of benzoic acid into hippuric acid. Prov Med J Retrosp Med Sci 1842;4(13):256-7
3. Knights KM, Sykes MJ, Miners JO. Amino acid conjugation: contribution to the metabolism and toxicity of xenobiotic carboxylic acids. Expert Opin Drug Metab Toxicol 2007;3(2):159-68
4. Knights KM, Miners JO. Amino acid conjugation: a novel route of xenobiotic carboxylic acid metabolism in man. 1st edition. John Wiley & Sons, Inc; 2012
5. Wallig MA. Glucuronidation and susceptibility to chemical carcinogenesis. Toxicol Sci 2004;78(1):1-2
6. Grillo MP. Drug-S-acyl-glutathione thioesters: synthesis, bioanalytical properties, chemical reactivity, biological formation and degradation. Curr Drug Metab 2011;12(3):229-44
7. Sidenius U, Skonberg C, Olsen J, Hansen SH. In vitro reactivity of carboxylic acid-CoA thioesters with glutathione. Chem Res Toxicol 2004;17:75-81
8. Oates PS, West AR. Heme in intestinal epithelial cell turnover, differentiation, detoxifi cation, infl ammation, carcinogenesis, absorption and motility. World J Gastroenterol 2006;12(27):4281-95
9. Potter T, Lewis R, Luker T, et al. In silico prediction of acyl glucuronide reactivity. J Comput Aided Mol Des 2011;25:997-1005
10. Eaton S, Bartlett K, Pourfarzam M. Mammalian mitochondrial b-oxidation. Biochem J 1996;320:345-57
11. Leonardi R, Zhang Y, Rock CO, et al. Back in action. Prog Lip Res 2005;44:125-53
12. Mitchell GA, Gauthier N, Lesimple A, et al. Hereditary and acquired diseases of acyl-coenzyme A metabolism. Mol Genet Metab 2008;94(1):4-15
13. Zhang Y, Chohnan S, Virga KG, et al. Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme a homeostasis. Chem Biol 2007;14(3):291-302
14. Wanders RJA, Vreken P, den Boer MEJ, et al. Disorders of mitochondrial fatty acyl-CoA b-oxidation. J Inher Metab Dis 1999;22:442-87
15. Knights KM. Role of hepatic fatty acid: coenzyme A ligases in the metabolism of xenobiotic carboxylic acids. Clin Exp Pharmacol Physiol 1998;25:776-82
16. Schachter D, Taggart JV. Benzoyl coenzyme A and hippurate synthesis. J Biol Chem 1953;203:925-34
17. Mashek DG, Bornfeldt KE, Coleman RA, et al. Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res 2004;45:1958-61
18. Knights KM, Drogemiller CJ. Xenobiotic-CoA Ligases: kinetic and Molecular Characterization. Curr Drug Metab 2000;1:49-66
19. Kasuya F, Igarashi K, Fukui M, Nokihara K. Purification and characterization of a medium chain acyl-coenzyme A synthetase. Drug Metab Dispos 1996;24(8):879-83
20. Killinberg PG, Davidson ED, Webster LT. Evidence for a medium-chain fatty acid: coenzyme A ligase (adenosine monophosphate) that activates salicylate. Mol Pharmacol 1971;7:260-8
21. Vessey DA, Chen W, Ramsay RR. Effect of carboxylic acid xenobiotics and their metabolites on the activity of carnitine acyltransferases. Biochem J 1991;279:895-7
22. Vessey DA, Hu J, Kelley M. Interaction of salicylate and ibuprofen with the carboxylic acid: coA ligases from bovine liver mitochondria. J Biochem Toxicol 1996;11(2):73-8
23. Pessayre D, Fromenty B, Berson A, et al. Central role of mitochondria in drug-induced liver injury. Drug Metab Rev 2012;44(1):34-87
24. Vessey DA, Hu J. Isolation from bovine liver mitochondria and characterization of three distinct carboxylic acid: coA ligases with activity toward xenobiotics. J Biochem Toxicol 1995;10(6):329-37
25. Vessey DA, Kelley M. Characterization of the reaction mechanism for the XL-I form of bovine liver xenobiotic/mediumchain fatty acid:coA ligase. Biochem J 2001;357:283-8
26. Watkins PA, Maiguel D, Jia Z, Pevsner J. Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. J Lipid Res 2007;48:2736-50
27. Vessey DA, Kelley M, Warren RS. Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short-and medium-chain fatty acids and xenobiotic carboxylic acids. Biochim Biophys Acta 1999;1428:455-62
28. Vessey DA, Lau E, Kelley M, Warren RS. Isolation, Sequencing, and Expression of a cDNA for the HXM-A Form of Xenobiotic/Medium-Chain Fatty Acid:coA Ligase from Human Liver Mitochondria. J Biochem Mol Toxicol 2003;17(1):1-6
29. Kasuya F, Yamaoka Y, Osawa E, et al. Difference of the liver and kidney in glycine conjugation of ortho-substituted benzoic acids. Chem Biol Interact 2000;125:39-50
30. Yao KW, Mao LF, Luo MJ, Schulz H. The relationship between mitochondrial activation and toxicity of some substituted carboxylic acids. Chem Biol Interact 1994;90(3):225-34
31. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995;67(1):101-54 . A very good introduction to hepatotoxicity resulting from inhibition of mitochondrial b-oxidation. Explains how some pharmaceuticals cause CoASH sequestration and consequences thereof.
32. Ruff LJ, Brass EP. Metabolic effects of pivalate in isolated rat hepatocytes. Toxicol Appl Pharmacol 1991;110(2):295-302
33. Begriche K, Massart J, Robin MA, et al. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 2011;54:773-94
34. Guarente L. Sirtuins, aging, and medicine. N Engl J Med 2011;364:2235-44
35. Sakuma T. Alteration of urinary carnitine profile induced by benzoate administration. Arch Dis Child 1991;66:873-5
36. Feoli-Fonseca JC, Lambert M, Mitchell G, et al. Chronic sodium benzoate therapy in children with inborn errors of urea synthesis: effect on carnitine metabolism and ammonia nitrogen removal. Biochem Mol Med 1996;57:31-6
37. Fenton WA, Gravel RA, Rosenblatt DS. Part 9: organic acids. Chapter 94: disorders of propionate and methylmalonate metabolism. In: Vale D, Beaudet AL, Vogelstein B, et al., editors, The online metabolic and molecular bases of inherited diseases. McGraw Hill, New York; 2013
38. Geelen MJH. Medium-chain fatty acids as short-term regulators of hepatic lipogenesis. Biochem J 1994;302:141-6
39. Glasgow JFT, Middleton B. Reye syndrome-insights on causation and prognosis. Arch Dis Child 2001;85:351-3
40. Zhang H, Lang Q, Li J, et al. Molecular cloning and characterization of a novel human glycine N-acyltransferase gene GLYAT1, which activates transcriptional activity of HSE pathway. Int J Mol Sci 2007;8:433-44
41. Hunt MC, Siponen MI, Alexson SEH. The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism. Biochim Biophys Acta 2012;1822:1397-410
42. Bartlett K, Gompertz D. The specificity of glycine-N-acylase and acylglycine excretion in the organicacidaemias. Biochem Med 1974;10(1):15-23
43. Bonafe L, Troxler H, Kuster T, et al. Evaluation of urinary acylglycines by electrospray tandem mass spectrometry in mitochondrial energy metabolism defects and organic acidurias. Mol Genet Metab 2000;69:302-11
44. Rechner AR, Kuhnle G, Bremner P, et al. The metabolic fate of dietary polyphenols in humans. Free Radic Biol Med 2002;33(2):220-35
45. Williams HRT, Cox IJ, Walker DG, et al. Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Chron's disease. BMC Gastroenterol 2010;10:108
46. Paterson JR, Lawrence JR. Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer. Q J Med 2001;94:445-8
47. Furuya KN, Durie PR, Roberts EA, et al. Glycine conjugation of Para-Aminobenzoic Acid (PABA): a quantitative test of liver function. Clin Biochem 1995;28(5):531-40
48. Furst DE, Gupta N, Paulus HE. Salicylate metabolism in twins. Evidence suggesting a generic influence and induction of salicylurate formation. J Clin Invest 1977;60:32-42
49. Dorne JLCM, Walton K, Renwick AG. Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation). Food Chem Toxicol 2004;42:397-421
50. Tanaka K, Isselbacher KJ. The isolation and identification of N-isovalerylglycine from urine of patients with isovaleric acidemia. J Biol Chem 1967;242(12):2966-72
51. Tanaka K, Budd WA, Efron ML, Isselbacher KJ. Isovaleric acidemia: a new genetic defect of leucine metabolism. Biochemistry 1966;56:236-42
52. Ogier DB, Saudubray JM. Branched-chain organic acidurias. Semin Neonatol 2002;7(1):65-74
53. Gompertz D. Inborn errors of organic acid metabolism. Clin Endocrinol Metab 1974;3:107-130
54. Gron I, Gregersen N, Kolvraa S, Rasmussen K. Formation of Ndicarboxyl-mono-glycines catalyzed bt glycine-N-Acylase. Biochem Med 1978;19:133-40
55. Krieger I, Tanaka K. Therapeutic effects of glycine in isovaleric acidemia. Pediatr Res 1976;10:25-9
56. Dercksen M, Duran M, Ijlst L, et al. Clinical variability of isovaleric acidemia in a genetically homogeneous population. J Inherit Metab Dis 2012;2012:17
57. Sweetman L, Williams JC. Part 9: organic acids Chapter 93: branched chain organic acidurias. In: Vale D, Beaudet AL, Vogelstein B, et al., editors, The online metabolic and molecular bases of inherited diseases; McGraw Hill, New York; 2013
58. Nandi DL, Lucas SV, Webster LT Jr. Benzoyl-coenzyme A:glycine N-acyltransferase and phenylacetyl-coenzyme A:glycine N-acyltransferase from bovine liver mitochondria. Purification and characterization. J Biol Chem 1979;254(15):7230-7
59. Gregus Z, Fekete T, Varga F, Klaassen CD. Dependence of glycine conjugation on availability of glycine: role of the glycine cleavage system. Xenobiotica 1993;23(2):141-53
60. van der Westhuizen FH, Pretorius PJ, Erasmus E. The utilization of alanine, glutamic acid, and serine as amino acid substrates for glycine N-acyltransferase. J Biochem Mol Toxicol 2000;14(2):102-9
61. Loots D, Erasmus E, Mienie LJ. Identification of 19 new metabolites induced by abnormal amino acid conjugation in isovaleric acidemia. Clin Chem 2005;51(8):1510-12
62. Vest MF, Salzberg R. Conjugation reactions in the newborn infant: the metabolism of para-aminobenzoic acid. Arch Dis Childh 1965;40:97-105
63. Campbell L, Wilson HK, Samuel AM, Gompertz D. Interactions of m-xylene and aspirin metabolism in man. Br J Ind Med 1988;45(2):127-32
64. Temellini A, Mogavero S, Giulianotti PC, et al. Conjugation of benzoic acid with glycine in human liver and kidney: a study on the interindividual variability. Xenobiotica 1993;23(12):1427-33
65. Duffy LF, Kerzner B, Seeff L, et al. Preliminary assessment of glycine conjugation of para-aminobenzoic acid as a quantitative test of liver function. Clin Biochem 1995;28(5):527-30
66. Lebel S, Nakamachi Y, Hemming A, et al. Glycine conjugation of para-aminobenzoic acid (PABA): a pilot study of a novel prognostic test in acute liver failure in children. J Pediatr Gastroenterol Nutr 2003;36(1):62-71
67. Gregus Z, Fekete T, Varga F, Klaassen CD. Effect of valproic acid on glycine conjugation of benzoic acid. J Pharmacol Exp Ther 1993;267(3):1068-75
68. Matsuo M, Terai K, Kameda N, et al. Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N- acyltransferase in human hepatocellular carcinoma. Biochem Biophys Res Commun 2012;420(4):901-6
69. Jain M, Nilsson R, Sharma S, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012;336(6084):1040-4
70. Renwick SB, Snell K, Baumann U. The crystal structure of human cytosolic serine hydroxymethyltransferase: a target for cancer chemotherapy. Structure 1998;6(9):1105-16
71. Guo Y, Zhang L, Liu Y, et al. Suggestion of GLYAT gene underlying variation of bone size and body lean mass as revealed by a bivariate genome-wide association study. Hum Genet 2013;132(2):189-99
72. Gregersen N, Kolvraa S, Mortensen PB. Acyl-CoA: glycine N-acyltransferase: in vitro studies on the glycine conjugation of straight-and branched-chained acyl-CoA esters in human liver. Biochem Med Metab Biol 1986;35(2):210-18
73. Kelley M, Vessey D. The effects of ions on the conjugation of xenobiotics by the aralkyl-CoA and arylacetyl-CoA Nacyltransferases from bovine liver mitochondria. J Biochem Toxicol 1990;5:125-35
74. Kelley M, Vessey D. Characterization of the acyl-CoA: amino acid N-acyltransferases from primate liver mitochondria. J Biochem Toxicol 1994;9:153-8
75. Kelley M, Vessey DA. Isolation and characterization of mitochondrial acyl-CoA: glycine N-acyltransferases from kidney. J Biochem Toxicol 1993;8(2):63-9
76. Kolvraa S, Gregersen N. Acyl-CoA: glycine N-acyltransferase: organelle localization and affinity toward straightand branched-chained acyl-CoA esters in rat liver. Biochem Med Metab Biol 1986;36(1):98-105
77. Lau EP, Haley BE, Barden RE. Photoaffinity labeling of acyl-coenzyme A:glycine N-acyltransferase with p-azidobenzoyl-coenzyme A. Biochemistry 1977;16(12):2581-5
78. Mawal YR, Qureshi IA. Purification to homogeneity of mitochondrial acyl coa: glycine n-acyltransferase from human liver. Biochem Biophys Res Commun 1994;205(2):1373-9
79. Schachter D, Taggart JV. Glycine Nacylase: purification and properties. J Biol Chem 1954;208(1):263-75
80. Vessey DA, Lau EP. Determination of the Sequence of the arylacetyl acyl-CoA: amino acid N-acyltransferase from bovine liver mitochondria and its homology to the aralkyl acyl-CoA:amino acid N-acyltransferase. J Biochem Mol Toxicol 1998;12(5):275-9
81. Webster LT, Siddiqui UA, Lucas SV, et al. Identification of separate acyl-CoA:glycine and acyl-CoA:L-glutamine N-acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man. J Biol Chem 1976;251(11):3352-8
82. Schachter D, Taggart JV. Product inhibition in the clygine N-acylase reaction. J Biol Chem 1954;211(1):271-8
83. Huang M, Jin C, Liu Y, et al. Exposure of workers to a mixture of toluene and xylenes. I metabolism. Occup Environ Med 1994;51:42-6
84. van der Sluis R, Badenhorst CPS, van der Westhuizen FH, van Dijk AA. Characterisation of the influence of genetic variations on the enzyme activity of a recombinant human glycine N-acyltransferase. Gene 2013;515:447-53
85. Badenhorst CPS, Jooste M, van Dijk AA. Enzymatic characterization and elucidation of the catalytic mechanism of a recombinant bovine glycine N-acyltransferase. Drug Metab Dispos 2012;40(2):346-52
86. Lino Cardenas CL, Bourgine J, Cauffiez C, et al. Genetic polymorphisms of Glycine N-acyltransferase (GLYAT) in a French Caucasian population. Xenobiotica 2010;40(12):853-61
87. Yamamoto A, Nonen S, Fukuda T, et al. Genetic polymorphisms of glycine N-acyltransferase in Japanese individuals. Drug Metab Pharmacokinet 2009;24(1):114-17
88. Waluk DP, Schultz N, Hunt MC. Identification of glycine N-acyltransferase-like 2 (GLYATL2) as a transferase that produces N-acyl glycines in humans. FASEB J 2010;24(8):2795-803
89. Waluk DP, Sucharski F, Sipos L, et al. Reversible lysine acetylation regulates activity of human glycine N-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signaling molecules. J Biol Chem 2012;287(20):16158-67
90. Bradshaw HB, Walker JM. The expanding field of cannabimimetic and related lipid mediators. Br J Pharmacol 2005;144:459-65
91. Melendez-Hevia E, De Paz-Lugo P, Cornish-Bowden A, Cardenas ML. A weak link in metabolism: the metabolic capacity for glycine biosynthesis does not satisfy the need for collagen synthesis. J Biosci 2009;34(6):853-72
92. Lewis RM, Godfrey KM, Jackson AA, et al. Low serine hydroxymethyltransferase activity in the human placenta has important implications for fetal glycine supply. J Clin Endocrinol Metab 2005;90(3):1594-8
93. Jackson AA. The glycine story. Eur J Clin Nutr 1991;45(2):59-65
94. Piper WN, Condie LW, Tephly TR. The role pf substrates for glycine acyltransferase in the reversal of chemically induced porphyria in the rat. Arch Biochem Biophy 1973;159:671-7
95. van der Westhuizen FH, Terblanche E, Mienie LJ. Benzoylserine and benzoylthreonine in propionic acidaemia treated with sodium benzoate. SAMJ 1999;89(12):125-7
96. Kastanos EK, Woldman YY, Appling DR. Role of mitochondrial and cytoplasmic serine hydroxymethyltransferase isozymes in de novo purine synthesis in saccharomyces cerevisiae. Biochemistry 1997;36:14956-64
97. Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010;9:447-64
98. Kimura I, Inoue D, Maeda T, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). PNAS 2011;108(19):8030-5
99. Vessey DA. Isolation and preliminary characterization of the medium-chain fatty acid:coA ligase responsible for activation of short-and medium-chain fatty acids in colonic mucosa from swine. Dig Dis Sci 2001;46:438-42
100. Holmes E, Li JV, Athanasiou T, et al. Microbes and Metabolism. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol 2011;19(7):349-59
101. Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 2011;5:71-86